Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Using Machine Learning (XGBoost) to Predict Outcomes After Infrainguinal Bypass for Peripheral Artery Disease

作者:Ben Li, Naomi Eisenberg, Derek Beaton, Douglas S. Lee, Badr A. Aljabri, Raj Verma, Duminda Nalaka Wijeysundera, Ori David Rotstein, Charles de Mestral, Muhammad Mamdani, Graham Roche‐Nagle, Mohammed A. Al-Omran · 发表于:Annals of Surgery · 年份:2023 · DOI:10.1097/sla.0000000000006181 · 被引用次数:35 · 研究领域:Peripheral Artery Disease Management、Cardiac, Anesthesia and Surgical Outcomes、Cerebrovascular and Carotid Artery Diseases

OBJECTIVE: To develop machine learning (ML) algorithms that predict outcomes after infrainguinal bypass. BACKGROUND: Infrainguinal bypass for peripheral artery disease carries significant surgical risks; however, outcome prediction tools remain limited. METHODS: The Vascular Quality Initiative database was used to identify patients who underwent infrainguinal bypass for peripheral artery disease between 2003 and 2023. We identified 97 potential predictor variables from the index hospitalization [68 preoperative (demographic/clinical), 13 intraoperative (procedural), and 16 postoperative (in-hospital course/complications)]. The primary outcome was 1-year major adverse limb event (composite of surgical revision, thrombectomy/thrombolysis, or major amputation) or death. Our data were split into training (70%) and test (30%) sets. Using 10-fold cross-validation, we trained 6 ML models using preoperative features. The primary model evaluation metric was the area under the receiver operating characteristic curve (AUROC). The top-performing algorithm was further trained using intraoperative and postoperative features. Model robustness was evaluated using calibration plots and Brier scores. RESULTS: Overall, 59,784 patients underwent infrainguinal bypass, and 15,942 (26.7%) developed 1-year major adverse limb event/death. The best preoperative prediction model was XGBoost, achieving an AUROC (95% CI) of 0.94 (0.93-0.95). In comparison, logistic regression had an AUROC (95% CI) of 0.6...